Exhibit 99.1
image.jpg

Xylem Inc.
301 Water Street SE, Suite 200
Washington, DC 20003
Tel +1.202.869.9150

Contacts:MediaInvestors
Press OfficeMichael Travers
+1 (978) 704-5149+1 (724) 772-1597
PressOffice@xylem.comMichael.Travers@xylem.com

Xylem Reports Second Quarter 2026 Results

Second-Quarter Highlights

•Orders of $3.1 billion, up 42% on a reported basis and 41% organically
•Revenue of $2.3 billion, up 2% on a reported basis and 1% organically
•Earnings per share of $1.11, up 19%; $1.46 on an adjusted basis, up 16%

WASHINGTON, D.C., July 28, 2026 -- Xylem Inc. (NYSE: XYL), a leading global water solutions company dedicated to solving the world’s most challenging water issues, today reported second-quarter 2026 results. The Company delivered total revenue of $2.3 billion, on strong execution. Second-quarter earnings per share were up 19 percent on a reported basis and 16 percent on an adjusted basis.

“The demand drivers behind our business continue to strengthen,” said Matthew Pine, Xylem’s CEO. “Water is becoming increasingly strategic for both utilities and industrial customers. We’ve spent the past several years positioning Xylem for this. Now we’re seeing that strategy create new opportunities and strengthen our competitive position. With a resilient municipal foundation, increasing exposure to attractive industrial markets and a more focused portfolio, we believe Xylem is well positioned for long-term growth and profitability.”

“The opportunities we see today extend well beyond any single end market,” Pine continued. “The growth of AI infrastructure is increasing the strategic importance of water across a broader industrial ecosystem from semiconductors and power generation to mining and other critical industries. At the same time, we are seeing increasing demand across sectors such as food and beverage and life sciences, where water quality, reliability and operational performance are essential. These trends are broadening our opportunity set and reinforcing our confidence in the durability of our long-term strategy.”

Net income attributable to Xylem for the quarter was $263 million, or $1.11 per share. Net income margin increased 150 basis points to 11.3 percent. These results are driven by strong operational performance and lower restructuring and realignment costs, partially offset by increased income tax expense and loss on sale of businesses. Adjusted net income attributable to Xylem was $345 million, or $1.46 per share, which excludes purchase accounting intangible
1

amortization, the loss on sale of businesses, restructuring and realignment costs, and special charges.

Second-quarter adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) margin was 23.3 percent, reflecting a year-over-year increase of 150 basis points. Productivity savings, strong price realization and mix drove the margin expansion, exceeding the impact of inflation and lower volumes.

Outlook

Xylem now forecasts full-year 2026 revenue of approximately $9.2 billion, up approximately 2 percent on a reported basis, versus 2 to 3 percent previously guided, and up approximately 2 to 3 percent on an organic basis, versus 2 to 4 percent previously guided.

Full-year 2026 adjusted EBITDA margin is expected to be approximately 23.1 to 23.5 percent, an increase of 90 to 130 basis points from Xylem’s 2025 adjusted results. This results in full-year adjusted earnings per share of $5.55 to $5.70, up from the previous guidance range of $5.35 to $5.60. Full-year free cash flow margin is still expected to be approximately 10.2 to 11.0 percent.

Further 2026 planning assumptions are included in Xylem’s second-quarter 2026 earnings materials posted at www.xylem.com/investors. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

Supplemental information on Xylem’s Second-quarter earnings, as well as definitions of and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.

###

About Xylem

Xylem (XYL) is a Fortune 500 global water solutions company that empowers customers and communities to build a more water-secure world. Our 22,000 employees delivered revenue of $9 billion in 2025, optimizing water and resource management with innovation and expertise. Join us at www.xylem.com and Let’s Solve Water.

Xylem uses our Investor Relations website, www.xylem.com/en-us/investors, as a means of disclosing information which may be of interest or material to our investors and for complying with disclosure obligations under Regulation FD. Accordingly, investors should monitor our Investor Relations website, in addition to following our press releases, SEC filings, public conference calls, webcasts, and social media.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” "contemplate," "predict," “forecast,” “likely,” “believe,” “target,” “goal,” “objective,” “will,” “could,” “would,” “should,” "potential," "may" and similar expressions or their negative, may, but are not necessary to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that: are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions or goals (including those related to our social, environmental and other sustainability goals); or address
2

possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: the impact of overall industry and general economic conditions, including industrial, governmental, and public and private sector spending, interest rates, availability of funding for our customers, inflation and governments’ related monetary policy in response, and the strength of the real estate markets, on economic activity and our operations; geopolitical matters, including nationalism, protectionism and anti-global sentiment, volatility involving the U.S. and other governments, ongoing, escalation or outbreak of international conflicts, and regulatory, trade protection, economic and other risks associated with our global sales and operations; manufacturing and operating cost increases due to macroeconomic conditions, including inflation, energy supply, supply chain shortages, logistics challenges, labor shortages, trade agreements, tariffs, and other trade protection measures, and other factors; demand for our products, disruption, competition or pricing pressures in the markets we serve; cybersecurity incidents, data breaches, or other disruptions of information technology systems on which we or our customers rely, or involving our connected products and services; lack of availability or delays in receiving parts and raw materials from our supply chain, including semiconductors or other key components; operational disruptions at our facilities or that of third parties upon which we rely; safe and compliant treatment and handling of water, wastewater and hazardous materials; failure to successfully execute large projects, including as respects performance guarantees and customers’ budgets, timelines and safety requirements; our ability to retain, compete for and attract leadership, other key talent and labor; defects, security, warranty and liability claims, and recalls related to our products; uncertainty around productivity, simplification, restructuring and realignment actions and related costs and savings; our ability to execute strategic investments for growth, including acquisitions and divestitures; availability, regulation or interference with radio spectrum used by certain of our products; volatility in served markets or impacts on our business and operations due to weather conditions, volatile weather events, or changing climate patterns; risks related to our sustainability efforts and related disclosures; fluctuations in foreign currency exchange rates; difficulty predicting our financial results; risk of future impairments to goodwill and other intangible assets; changes in our effective tax rates or tax expenses; failure to comply with, or changes in, laws or regulations, pertaining to our business conduct, operations, products and services, including anti-corruption, artificial intelligence, data privacy and security, trade, competition, the environment, and health and safety; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; matters related to intellectual property infringement or expiration of rights; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 and in subsequent filings we make with the Securities and Exchange Commission (“SEC”).

Forward-looking and other statements in this press release regarding our environmental and other sustainability plans and goals are not an indication that these statements are necessarily material to investors, to our business, operating results, financial condition, outlook, or strategy, to our impacts on sustainability matters or other parties, or are required to be disclosed in our filings with the SEC or other regulatory authorities, and are not intended to create legal rights or obligations. In addition, historical, current, and forward-looking social, environmental and sustainability-related statements may be based on: standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future.
3

All forward-looking statements made herein are based on information currently available to us as of the date of this press release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

4

XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited) (in millions, except per share data)
Three MonthsSix Months
For the periods ended June 30,2026202520262025
Revenue from products$1,953 $1,911 $3,710 $3,620 
Revenue from services383 390 751 750 
Revenue2,336 2,301 4,461 4,370 
Cost of revenue from products1,093 1,129 2,150 2,170 
Cost of revenue from services280 280 545 540 
Cost of revenue1,373 1,409 2,695 2,710 
Gross profit963 892 1,766 1,660 
Selling, general and administrative expenses503 503 975 963 
Research and development expenses59 58 115 114 
Restructuring and asset impairment charges11 26 42 47 
Operating income390 305 634 536 
Interest expense(7)(9)(11)(17)
Other non-operating (expense)/income, net(3)3 (3)7 
Loss on sale of businesses(16)— (12)(10)
Income before taxes364 299 608 516 
Income tax expense(103)(75)(158)(125)
Net income$261 $224 $450 $391 
Net loss attributable to non-controlling interests2 2 6 4 
Net income attributable to Xylem 263 226 456 395 
Earnings per share:
Basic$1.11 $0.93 $1.90 $1.62 
Diluted$1.11 $0.93 $1.90 $1.62 
Weighted average number of shares:
Basic236.3 243.4 239.5 243.3 
Diluted236.6 243.9 240.0 243.8 


5

XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(in millions)
June 30,
2026		December 31,
2025
  
ASSETS
Current assets:
Cash and cash equivalents$1,276 $1,479 
Receivables, less allowances for discounts, returns and credit losses of $54 and $68 in 2026 and 2025, respectively
1,875 1,759 
Inventories1,016 983 
Prepaid and other current assets219 244 
Assets held for sale8 176 
Total current assets4,394 4,641 
Property, plant and equipment, net1,167 1,159 
Goodwill8,256 8,332 
Other intangible assets, net2,150 2,272 
Other non-current assets1,375 1,230 
Total assets$17,342 $17,634 
LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$1,013 $1,013 
Accrued and other current liabilities1,180 1,237 
Short-term borrowings and current maturities of long-term debt531 534 
Liabilities held for sale— 72 
Total current liabilities2,724 2,856 
Long-term debt2,395 1,408 
Accrued post-retirement benefit obligations301 317 
Deferred income tax liabilities446 405 
Other non-current accrued liabilities810 899 
Total liabilities6,676 5,885 
Redeemable non-controlling interest242 258 
Stockholders’ equity:
Common Stock – par value $0.01 per share:
Authorized 750.0 shares, issued 260.3 shares and 259.9 shares in 2026 and 2025, respectively
3 3 
Capital in excess of par value8,787 8,759 
Retained earnings3,956 3,706 
Treasury stock – at cost 26.8 shares and 16.3 shares in 2026 and 2025, respectively
(2,023)(768)
Accumulated other comprehensive loss(302)(220)
Total stockholders’ equity10,421 11,480 
Non-controlling interests3 11 
Total equity10,424 11,491 
Total liabilities, redeemable non-controlling interest, and stockholders’ equity$17,342 $17,634 

6

XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(in millions)
For the periods ended June 30,20262025
Operating Activities
Net income$450 $395 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation130 137 
Amortization150 153 
Share-based compensation25 25 
Restructuring and asset impairment charges42 47 
Loss from sale of businesses12 10 
Other, net(27)6 
Payments for restructuring(49)(36)
Changes in assets and liabilities (net of acquisitions):
Changes in receivables(142)(103)
Changes in inventories(41)(27)
Changes in accrued expenses(13)(64)
Changes in accrued and deferred taxes1 (50)
Changes in long term receivables(104)(70)
Other, net(36)(85)
Net Cash – Operating activities398 338 
Investing Activities
Capital expenditures(179)(169)
Acquisition of businesses, net of cash acquired (1)(7)
Proceeds from sale of business, net of cash disposed59 50 
Proceeds from the sale of property, plant and equipment11 5 
Cash paid for investments(3)(3)
Cash paid for asset acquisition(2)(37)
Cash received from cross-currency swaps17 21 
Net Cash – Investing activities(98)(140)
Financing Activities
Short-term debt issued, net— 4 
Long-term debt issued, net990 — 
   Long-term debt repaid(6)(28)
Repurchase of common stock(1,243)(13)
Proceeds from exercise of employee stock options2 8 
Dividends paid(207)(196)
Other, net(20)(19)
Net Cash – Financing activities(484)(244)
Effect of exchange rate changes on cash(31)84 
Increase in cash classified within assets held for sale— 11 
Decrease in cash classified within assets held for sale12 — 
Changes in cash classified within assets held for sale12 11 
Net change in cash and cash equivalents(203)49 
Cash and cash equivalents at beginning of year1,479 1,121 
Cash and cash equivalents at end of period$1,276 $1,170 
Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest$29 $32 
Income taxes (net of refunds received)$157 $175 
7

Xylem Inc. Non-GAAP Measures
Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent non-GAAP measures that we consider to be key performance indicators, as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to similarly titled measures reported by other companies.
“Organic revenue” and “Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales or discontinuance of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.
“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” and "Adjusted Segment EBITDA" reflect the adjustments to EBITDA and segment EBITDA, respectively, to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.
“Adjusted EBITDA Margin” and “Adjusted Segment EBITDA Margin” defined as adjusted EBITDA and adjusted segment EBITDA divided by total revenue and segment revenue, respectively.
“Adjusted Operating Income”, “Adjusted Segment Operating Income”, “Adjusted Net Income” and “Adjusted EPS” defined as operating income, segment operating income, net income attributable to Xylem and earnings per share attributable to Xylem, adjusted to exclude restructuring and realignment costs, amortization of acquired intangible assets, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.
“Adjusted Operating Margin” and “Adjusted Segment Operating Margin” defined as adjusted operating income and adjusted segment operating income divided by total revenue and segment revenue, respectively.
“Free Cash Flow” defined as net cash from operating activities, less capital expenditures, as reported in the Statement of Cash Flows. Our definition of free cash flow does not consider certain non-discretionary cash payments, such as debt.
"Free Cash Flow Margin" defined as free cash flow, adjusted (as applicable) for significant cash paid or received for non-operational tax, acquisition or divestiture activities; divided by revenue.
“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.
“Special charges” defined as non-recurring costs incurred by the Company, such as those related to acquisitions and integrations, divestitures, non-cash impairment charges and other special charges. In 2026, these charges include reductions of expense related to the refunds of certain tariffs previously imposed under the International Emergency Economic Powers Act ("IEEPA").
“Tax-related special items” defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, excess tax benefits/losses and other discrete tax adjustments.
8

Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic Orders
($ Millions)
(As Reported - GAAP)(As Adjusted - Organic)
(A)(B)(C)(D)(E)(F)=B+C+D+E(G)=F/(A-D)
OrdersOrdersChange 2026 v. 2025% Change 2026 v. 2025Book-to-BillAcquisitionsDivestituresFX ImpactChange
Adj.
2026 v. 2025		% Change
Adj. 2026 v. 2025
20262025
Six Months Ended June 30
Xylem Inc.5,314 4,332 $982 23 %119 %(27)28 (111)872 20 %
Water Infrastructure1,344 1,298 $46 4 %105 %(21)8 (45)(12)(1)%
Applied Water1,050 974 $76 8 %111 %— — (20)56 6 %
Measurement and Control Solutions905 839 $66 8 %89 %— 20 (14)72 9 %
Water Solutions and Services2,015 1,221 $794 65 %167 %(6)— (32)756 62 %
Quarter Ended June 30
Xylem Inc.3,086 2,174 912 42 %132 %(15)23 (41)879 41 %
Water Infrastructure669 672 (3)— %98 %(13)3 (13)(26)(4)%
Applied Water538 488 50 10 %107 %— — (5)45 9 %
Measurement and Control Solutions430 437 (7)(2)%85 %— 20 (3)10 2 %
Water Solutions and Services1,449 577 872 151 %225 %(2)— (20)850 147 %
Quarter Ended March 31
Xylem Inc.2,228 2,158 70 3 %105 %(12)5 (70)(7)— %
Water Infrastructure675 626 49 8 %112 %(8)5 (32)14 2 %
Applied Water512 486 26 5 %114 %— — (15)11 2 %
Measurement and Control Solutions475 402 73 18 %94 %— — (11)62 15 %
Water Solutions and Services566 644 (78)(12)%100 %(4)— (12)(94)(15)%


9

Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic Revenue
($ Millions)
(As Reported - GAAP)(As Adjusted - Organic)
(A)(B)(C)(D)(E)(F)=B+C+D+E(G)=F/(A-D)
RevenueRevenueChange 2026 v. 2025% Change 2026 v. 2025AcquisitionsDivestituresFX
Impact		Change Adj. 2026 v. 2025% Change Adj. 2026 v. 2025
20262025
Six Months Ended June 30
Xylem Inc.4,461 4,370 91 2 %(12)36 (94)21 — %
Water Infrastructure1,286 1,231 55 4 %(7)7 (43)12 1 %
Applied Water949 918 31 3 %— — (19)12 1 %
Measurement & Control Solutions1,016 1,030 (14)(1)%— 29 (15)— — %
Integrated Solutions & Services1,210 1,191 19 2 %(5)— (17)(3)— %
Quarter Ended June 30
Xylem Inc.2,336 2,301 35 2 %(7)31 (29)30 1 %
Water Infrastructure683 650 33 5 %(4)2 (14)17 3 %
Applied Water501 483 18 4 %— — (5)13 3 %
Measurement and Control Solutions508 540 (32)(6)%— 29 (4)(7)(1)%
Water Solutions and Services644 628 16 3 %(3)— (6)7 1 %
Quarter Ended March 31
Xylem Inc.2,125 2,069 56 3 %(5)5 (65)(9)— %
Water Infrastructure603 581 22 4 %(3)5 (29)(5)(1)%
Applied Water448 435 13 3 %— — (14)(1)— %
Measurement and Control Solutions508 490 18 4 %— — (11)7 1 %
Water Solutions and Services566 563 3 1 %(2)— (11)(10)(2)%
10

Xylem Inc. Non-GAAP Reconciliation
Adjusted Diluted EPS
($ Millions, except per share amounts)
Q2 2026Q2 2025
As ReportedAdjustmentsAdjustedAs ReportedAdjustmentsAdjusted
Total Revenue2,336 — 2,336 2,301 — 2,301 
Operating Income390 57  a 447 305 97  a 402 
Operating Margin16.7 %19.1 %13.3 %17.5 %
Interest Expense(7)— (7)(9)— (9)
Other Non-Operating Income (Expense)(3)7 b4 3 — b3 
Gain/(Loss) from Sale of Business(16)16 c— — — c— 
Income before Taxes364 80 444 299 97 396 
Provision for Income Taxes(103)2 d(101)(75)(15)d(90)
Net Income 261 82 343 224 82 306 
Net Loss Attributable to Non-controlling Interests2 — 2 2 — 2 
Net Income Attributable to Xylem263 82 345 226 82 308 
Diluted Shares236.6 236.6 243.9 243.9 
Diluted EPS$1.11 $0.35 $1.46 $0.93 $0.33 $1.26 
Q2 YTD 2026Q2 YTD 2025
As ReportedAdjustmentsAdjustedAs ReportedAdjustmentsAdjusted
Total Revenue4,461 — 4,461 4,370 — 4,370 
Operating Income634 155  a 789 536 191  a 727 
Operating Margin14.2 %17.7 %12.3 %16.6 %
Interest Expense(11)— (11)(17)— (17)
Other Non-Operating Income (Expense)(3)12 b9 7 — b7 
Gain/(Loss) From Sale of Business(12)12 c— (10)10 c— 
Income before Taxes608 179 787 516 201 717 
Provision for Income Taxes(158)(18)d(176)(125)(37)d(162)
Net Income450 161 611 391 164 555 
Net Loss Attributable to Non-controlling interests6 — 6 4 — 4 
Net Income Attributable to Xylem456 161 617 395 164 559 
Diluted Shares240.0 240.0 243.8 243.8 
Diluted EPS$1.90 $0.67 $2.57 $1.62 $0.67 $2.29 
aQuarter-to-date:
Restructuring & realignment costs: 2026 - $15 million and 2025 - $29 million Special Charges: 2026 - $6 million of acquisition, divestiture & integration costs; offset by $16 million of IEEPA tariff refunds; 2025 - $9 million of acquisition, divestiture & integration costs and $4 million of intangible asset impairment charges Purchases accounting intangible amortization: 2026 - $52 million and 2025 - $55 million
Year-to-date:
Restructuring & realignment costs: 2026 - $53 million and 2025 - $56 million
Special charges: 2026 - $11 million of acquisition, divestiture & integration costs, offset by $16 million of IEEPA tariff refunds; 2025 - $17 million of acquisition & integration related costs and $8 million of intangible asset impairment charges
Purchase accounting intangible amortization: 2026 - $107 million and 2025 - $110 million
bOther special charges
cGain/(Loss) from sale of businesses as per income statement for all periods presented
dQuarter-to-date:
2026 - Net tax impact on pre-tax adjustments (notes a, b and c) of $13million, offset by $15 million of other tax special expense items; 2025 - Net tax impact on pre-tax adjustments (notes a,b and c) of $20 million, offset by $5 million of other tax special expense items; Year-to-date:
2026 - Net tax impact on pre-tax adjustments (notes a, b and c) of $34 million, offset by $16 million of other tax special expense items; 2025 - Net tax impact on pre-tax adjustments (notes a, b and c) of $42 million, offset by other tax special expense items of $5 million
11

Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter
($ Millions)
2026
Q1Q2Q3Q4Total
Net Income attributable to Xylem193 263 456 
Net Income Margin9.1 %11.3 %N/AN/A10.2 %
Depreciation65 65 130 
Amortization75 75 150 
Interest Expense (Income), net(4)2 (2)
Income Tax Expense55 103 158 
EBITDA384 508 — — 892 
Share-based Compensation13 12 25 
Restructuring & Realignment38 13 51 
Special Charges10 (3)7 
Loss/(Gain) from sale of businesses(4)16 12 
Loss attributable to non-controlling interest(4)(2)(6)
Adjusted EBITDA437 544 — — 981 
Revenue2,125 2,336 4,461 
Adjusted EBITDA Margin20.6 %23.3 %N/AN/A22.0 %
2025
Q1Q2Q3Q4Total
Net Income attributable to Xylem169 226 227 335 957 
Net Income Margin8.2 %9.8 %10.0 %14.0 %10.6 %
Depreciation68 69 64 66 267 
Amortization77 76 78 77 308 
Interest Expense (Income), net— 3 — (1)2 
Income Tax Expense50 75 71 35 231 
EBITDA364 449 440 512 1,765 
Share-based Compensation12 13 12 16 53 
Restructuring & Realignment27 29 30 45 131 
Special Charges12 13 9 2 36 
Loss/(Gain) from sale of businesses10 — 37 (16)31 
Loss attributable to non-controlling interest(2)(2)(1)(2)(7)
Adjusted EBITDA423 502 527 557 2,009 
Revenue2,069 2,301 2,268 2,397 9,035 
Adjusted EBITDA Margin20.4 %21.8 %23.2 %23.2 %22.2 %











12